I am a board-certified pathologist with expertise in soft tissue sarcoma and bone tumors. After my fellowships in oncologic pathology and sarcoma research at Memorial Sloan Kettering Cancer Center, I joined the faculty in 1999. As part of the sarcoma disease management team, I work alongside colleagues from surgery, medical oncology, and radiation therapy to care for patients with these very complicated diseases. My role is to establish accurate pathologic diagnosis, grading, and staging. These analyses guide treatment decisions. We have extensive expertise in diagnosing even the rarest forms of these tumors. Findings from molecular and genetics tests are usually incorporated within the pathology report for a more refined classification.
My research interests are focused on detection and molecular characterization of prognostic markers in soft tissue sarcomas, with particular emphasis on the molecular mechanisms and drug resistance in gastrointestinal stromal tumors (GIST), angiosarcoma, and a genetic subset of soft tissue sarcoma known as translocation-associated soft tissue sarcoma.
I have authored more than 160 peer-reviewed publications and lectured nationally and internationally.
I am fluent in English, French, and Romanian.